Dr. Wei Lu obtained his Ph.D. degree in Pharmaceutics from Fudan University in 2005 and received award National Excellent Doctoral Dissertation by Ministry of Education and Academic Degrees Committee of the State Council of China. He started his postdoctoral training in molecular imaging at University of Texas M.D. Anderson Cancer Center in 2006 and was promoted to instructor in 2009. In 2010, he was appointed as assistant professor of College of Pharmacy at University of Rhode Island and early promoted to associate professor (tenured) in 2015. Dr. Lu is now appointed as professor of School of Pharmacy at Fudan University.His research focuses on development of innovative nanomaterials for drug delivery. He is the editorial member of Chinese Journal of Nuclear Medicine and Molecular Imaging.
Drug delivery, Formulation, Nanomedicine, Molecular imaging
Education
Ph.D. in Pharmaceutics, 06/2005
Fudan University, China
B. S. in Pharmaceutical Science, 06/2000
Fudan University, China
Post-doctoral training (Molecular Imaging), 11/2006-09/2009
University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Professional Experiences
2015-Present Professor, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China
2015-Present Principle Investigator, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, China
2015 Associate Professor (Tenured), Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA
2010-2015 Assistant Professor (Tenure-track), Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI, USA
2009-2010 Instructor, Department of Experimental Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
2005-2006 Lecturer, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China
Teaching Activities
2016-present Graduate courses of pharmaceutical sciences, Fudan University 2010-2015 Pharm.D. core courses, University of Rhode Island
2010-2015 Graduate courses of pharmaceutical sciences, University of Rhode Island
Grants & Projects
1. PD-L1 and CTLA-4 dual immune checkpoint blockade and photodynamic therapy-integrated nanosystems for cancer therapy, NSFC 81673018, Role: PI
2. Biodegradable hollow CuS nanoparticles for photothermal cancer therapy, NIH R01EB018748, Role: PI
Awards & Honors
1. National Excellent Doctoral Dissertation by Ministry of Education and Academic Degrees Committee of the State Council of China
2. The first prize of The Ministry of Education Natural Science Award, China, 2011 (the 4th awardee)
3. The second prize of Shanghai Sci-Tech Progress Award, 2010 (the 4th awardee)
Selected Publications
1. Lu W*. Editorial for molecular imaging and theranostics. Acta Pharmaceutica Sinica B 2018;8: In press.
2. Wang P, Zheng X, Guo Q, Yang P, Pang X, Qian K, Lu W*, Zhang Q*, Jiang X. Systemic delivery of BACE1 siRNA through neuron-targeted nanocomplexes for treatment of Alzheimer's disease. Journal of Controlled Release 2018;279:220-33.
3. Liu Q#, Qian Y#, Li P#, Zhang S, Liu J, Sun X, Fulham M, Feng D, Huang G*, Lu W*, Song S*. 131I-Labeled copper sulfide-loaded microspheres to treat hepatic tumors via hepatic artery embolization. Theranostics 2018;8(3):785-99.
4. Li Y, Cupo M, Guo L, Scott J, Chen YT, Yan B, Lu W*. Enhanced reactive oxygen species through direct copper sulfide nanoparticle-doxorubicin complexation. Nanotechnology 2017;28(50):505101.
5. Li Y, Scott J, Chen YT, Guo L, Zhao M, Wang X, Lu W*. Direct dry-grinding synthesis of monodisperse lipophilic CuS nanoparticles. Materials Chemistry & Physics 2015;162:671-6.
6. Guo L, Yan DD, Yang D, Li Y, Wang X, Zalewski O, Yan B, Lu W*. Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano 2014;8(6):5670-81.
7. Guo L, Panderi I, Yan DD, Szulak K, Li Y, Chen YT, Ma H, Niesen DB, Seeram N, Ahmed A, Yan B, Pantazatos D, Lu W*. A comparative study of hollow copper sulfide nanoparticles and hollow gold nanospheres on degradability and toxicity. ACS Nano 2013;7(10):8780-93.
8. Li Y, Guo L, Lu W*. Laser ablation-enhanced transdermal drug delivery. Photonics and Lasers in Medicine 2013; 2(4): 315-22.
9. Song S, Xiong C, Lu W, Ku G, Huang G, Li C*. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET. Journal of Nuclear Medicine 2013;54(1):104-10.
10. Ramadan S, Guo L, Li Y, Yan B, Lu W*. Hollow copper sulfide nanoparticle-mediated transdermal drug delivery. Small 2012; 8(20): 3143-50.
